SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-11.89%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$206M
AUM Growth
+$206M
(-28%)
Cap. Flow
-$45.3M
Cap. Flow
% of AUM
-21.99%
Top 10 Holdings %
Top 10 Hldgs %
36.68%
Holding
74
New
5
Increased
16
Reduced
28
Closed
17
Top Buys
| 1 |
Amgen
AMGN
|
$5.53M |
| 2 |
Eli Lilly
LLY
|
$5.02M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$4.65M |
| 4 |
HNT
HEALTH NET INC
HNT
|
$4.25M |
| 5 |
McKesson
MCK
|
$3.57M |
Top Sells
| 1 |
STJ
St Jude Medical
STJ
|
$6.58M |
| 2 |
Elevance Health
ELV
|
$5.75M |
| 3 |
Tenet Healthcare
THC
|
$4.68M |
| 4 |
Humana
HUM
|
$3.53M |
| 5 |
FEIC
FEI COMPANY
FEIC
|
$3.32M |
Sector Composition
| 1 | Healthcare | 83.73% |
| 2 | Financials | 4.25% |
| 3 | Energy | 1.47% |
| 4 | Industrials | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cigna
CI
$80.3B
| $10.1M | 4.91% |
75,000
+15,000
| +25% | +$2.03M |
|
|
HNT
2
DELISTED
HEALTH NET INC
HNT
| $9.64M | 4.67% |
160,000
+70,600
| +79% | +$4.25M |
|
|
3
Humana
HUM
$36.5B
| $8.95M | 4.34% |
50,000
-19,700
| -28% | -$3.53M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $8.75M | 4.25% |
80,000
+10,300
| +15% | +$1.13M |
|
|
5
McKesson
MCK
$85.4B
| $8.33M | 4.04% |
45,000
+19,273
| +75% | +$3.57M |
|
6
HCA Healthcare
HCA
$94.5B
| $6.58M | 3.19% |
85,000
-34,300
| -29% | -$2.65M |
|
|
WCG
7
DELISTED
Wellcare Health Plans, Inc.
WCG
| $6.46M | 3.13% |
75,000
-30,000
| -29% | -$2.59M |
|
8
Biogen
BIIB
$19.4B
| $5.84M | 2.83% |
20,000
-4,800
| -19% | -$1.4M |
|
|
9
Amgen
AMGN
$155B
| $5.53M | 2.68% |
+40,000
| New | +$5.53M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $5.44M | 2.64% |
20,000
+100
| +0.5% | +$27.2K |
|
|
CELG
11
DELISTED
Celgene Corp
CELG
| $5.41M | 2.62% |
50,000
+10,300
| +26% | +$1.11M |
|
12
Gilead Sciences
GILD
$140B
| $5.4M | 2.62% |
55,000
+15,500
| +39% | +$1.52M |
|
13
CVS Health
CVS
$92.8B
| $5.31M | 2.57% |
55,000
-5,000
| -8% | -$482K |
|
14
Universal Health Services
UHS
$11.6B
| $5.27M | 2.56% |
42,222
-17,478
| -29% | -$2.18M |
|
15
Community Health Systems
CYH
$387M
| $5.2M | 2.52% |
121,664
-77,436
| -39% | -$3.31M |
|
|
16
Eli Lilly
LLY
$657B
| $5.02M | 2.44% |
+60,000
| New | +$5.02M |
|
|
17
Regeneron Pharmaceuticals
REGN
$61.5B
| $4.65M | 2.26% |
+10,000
| New | +$4.65M |
|
|
RAD
18
DELISTED
Rite Aid Corporation
RAD
| $4.55M | 2.21% |
750,000
+4,900
| +0.7% | +$29.7K |
|
19
Teva Pharmaceuticals
TEVA
$21.1B
| $4.48M | 2.17% |
79,400
-10,000
| -11% | -$565K |
|
20
Bristol-Myers Squibb
BMY
$96B
| $4.44M | 2.15% |
75,000
+5,500
| +8% | +$326K |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $4.17M | 2.02% |
40,000
+23,000
| +135% | +$2.4M |
|
|
ALXN
22
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.91M | 1.9% |
25,000
| – | – |
|
23
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.69M | 1.79% |
35,000
+10,000
| +40% | +$1.05M |
|
|
WBA
24
DELISTED
Walgreens Boots Alliance
WBA
| $3.32M | 1.61% |
40,000
-19,600
| -33% | -$1.63M |
|
|
LHCG
25
DELISTED
LHC Group LLC
LHCG
| $3.03M | 1.47% |
67,705
-12,295
| -15% | -$550K |
|